VASSILIKI A PAPADIMITRAKOPOULOU to Oropharyngeal Neoplasms
This is a "connection" page, showing publications VASSILIKI A PAPADIMITRAKOPOULOU has written about Oropharyngeal Neoplasms.
Connection Strength
0.108
-
Long-Term, Prospective Performance of the MD?Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):700-708.
Score: 0.076
-
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004 Mar 01; 10(5):1565-73.
Score: 0.032